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Myosin-IIBIn this study, we describe a new post-translational modiﬁcation at position −1 of the PDZ-binding motif in
the mutated in colorectal cancer (MCC) protein and its role in lamellipodia formation. Serine 828 at position
−1 of this motif is phosphorylated, which is predicted to increase MCC binding afﬁnity with the polarity pro-
tein Scrib. We show that endogenous MCC localizes at the active migratory edge of cells, where it interacts
with Scrib and the non-muscle motor protein Myosin-IIB. Expression of MCC harboring a phosphomimetic
mutation MCC-S828D strongly impaired lamellipodia formation and resulted in accumulation of Myosin-IIB
in the membrane cortex fraction. We propose that MCC regulates lamellipodia formation by binding to
Scrib and its downstream partner Myosin-IIB in a multiprotein complex. Importantly, we propose that the
function of this complex is under the regulation of a newly described phosphorylation of the PDZ-binding
motif at position −1.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Mutated in colorectal cancer (MCC) is emerging as a multifunc-
tional protein in epithelial cells. MCC is required for cell migration
of epithelial cells [1] and also affects several other cellular processes
and pathways, such as β-catenin (Wnt) signaling [2], NFκB signaling
[3,4], the DNA damage response [5], and the cell cycle [6]. MCC con-
tains a PDZ (PSD-95/Dlg/ZO-1) binding motif “ETSL” in its extreme
carboxy terminus, which binds the polarity protein Scrib [1,7] and is
predicted to interact with other cellular PDZ domain-containing
substrates. The importance of this motif in the physiological role of
MCC is underlined by its extreme evolutionary conservation. The con-
sensus motif X-T/S-X-L/V/I is described as one of the most common
protein–protein interaction motifs [8].
Scrib has four PDZ domains, two of which (PDZ-1 and PDZ-3) bind
MCC. Scrib is involved in a variety of cellular functions including cell
polarity and migration [9]. Scrib regulates cell migration by anchoring
the PAK-interacting exchange factor (β-PIX),which in turn activates the
p21 activating kinase (PAK) at the front of motile cells (lamellipodia).DZ, post synaptic density pro-
(DlgA), or Zonula occludens-1
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.
l rights reserved.This Scrib–βPIX–PAK complex regulates a number of downstream sub-
strates required for cell migration and cytoskeletal reorganization [10].
The molecular basis for MCC migratory activity is unknown, but unlike
Scrib, it may not involve the activation of Rac1, Cdc42 or PAK [1].
The mechanism by which the Scrib–MCC complex mediates its sig-
naling is still open to debate but is likely to involve precise spatial/
temporal localization of key regulatory proteins [11]. Here we show
that MCC interacts with both Scrib and the Myosin-IIB motor protein
and regulates lamellipodia formation through phosphorylation of its
PDZ-binding motif. Finally, we propose a mechanism by which Scrib
plays a scaffolding role in bringing MCC/Myosin-IIB in close proximity
with the βPIX/PAK complex. Importantly, this work presents the ﬁrst
functional report of a new post-translational modiﬁcation at position
−1 of the PDZ-binding motif.2. Materials and methods
2.1. Cell culture
Caco2, MCF10A, HCT116 and HCT15 human cancer cell lines were
obtained from the American Type Culture Collection and propagated
in MEM, DMEM-F12 or RPMI 1640 media supplemented with fetal
calf serum (10%), HEPES 10 mM, insulin 0.3 units/ml, 100 units/ml
penicillin, and 100 μg/ml streptomycin. The HCT15 cells have a com-
plete loss of endogenous MCC due to silencing of the MCC promoter
[12] and Caco2 cells show greatly reduced MCC expression.
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The following antibodies were used: anti-MCC (610740, BD Trans-
duction Laboratories, Franklin Lakes, NJ, USA), Scrib (C-20 sc-11049,
Santa Cruz Biotechnology, Santa Cruz, CA, USA), Myosin-IIB (M7939,
Sigma, St Louis, MO, USA), E-cadherin (610181, BD Bioscience),
beta-catenin (610153, BD Bioscience), total PAK (C-19 sc-881, Santa
Cruz Biotechnology), Flag M2 Afﬁnity Gel (2220, Sigma), pAKT
(9271, Cell Signaling, Danvers, MA, USA), GAPDH (4300, Ambion,
Austin, TX, USA), horseradish peroxidase-conjugated anti-mouse, or
anti-rabbit IgG (Amersham, GE Healthcare, Rydalmere, Australia).
2.3. Transfection
The empty pQCXIP vector, pQCXIP containing full-length MCC
cDNA (ampliﬁed from clone MGC:12731, Invitrogen) or MCC mutants
were transfected using Lipofectamine 2000 (Invitrogen, Carlsbad, CA,
USA). Site directed mutagenesis and full sequencing was carried out
as previously described [13].
2.4. In-gel protein tryptic digestion, LC–MS/MS
Endogenous MCC was immunoprecipitated from HCT116 cells
using anti-MCCmonoclonal antibody (BD Transduction Laboratories).
Immunoprecipitated endogenous MCC was run on 10% polyacryl-
amide gel and the SYPRO-stained MCC band was excised and
destained in 1 ml of 50% acetonitrile and 250 mM ammonium bicar-
bonate at room temperature for 45 min with shaking. The gel slice
was dehydrated by incubation in 1 ml of 100% acetonitrile for
10 min at room temperature. All solutions were carefully removed
prior to the addition of modiﬁed trypsin (12.5 ng/μl) in 100 mM
NH4HCO3 and incubation overnight at 37 °C. Peptides were extracted
by the addition of 0.1 ml of 5% formic acid and incubation at 37 °C for
1 h. Peptides were further extracted by the addition of 0.1 ml of 100%
acetonitrile and incubation at 37 °C for 1 h. The gel slice was
completely dehydrated by the addition of 0.5 ml of 100% acetonitrile
and incubation at 37 °C for 10 min. The entire supernatant was then
vacuum-dried. The peptides were redissolved in 20 μl of 5% formic
acid for LC–MS/MS analysis. Data were processed, searched, and
quantiﬁed using the MaxQuant software version 1.0.13.13 package
and searches were performed using Mascot server version 2.2 against
the entire International Protein Index (IPI) database. The settings
used for the Mascot search were as follows: two missed cleavages
were allowed; enzyme was trypsin cleaving after arginine and lysine;
variable modiﬁcations were methionine oxidation, propionamide
cysteine, and phosphorylation of serine, threonine, or tyrosine; no
ﬁxed modiﬁcations were used; a mass tolerance of 6 ppm was used
for precursor ions; and a MS/MS tolerance of 0.5 Da was used for frag-
ment ions. False recovery rate was less than 1% and localization score
cut-off was greater than 75%.
2.5. Immunoﬂuorescence microscopy
MCF10A and Caco2 cells were cultured as described above on glass
coverslips. Cells were then ﬁxed with fresh 4% paraformaldehyde
in PBS for 15 min at room temperature (RT). The cells were then
permeabilized in 0.5% triton for 5 min and blocked with 20% FCS.
Labeling was performed in PBS containing 4% FCS for 45 min at RT using
the appropriate primary antibody. Primary antibodies were detected
with Alexa Fluor Cy2- or Cy3-conjugated secondary antibodies 1:500
(Invitrogen), DNA was stained with 4′,6-diamidino-2-phenylindole
1:200 (DAPI). Cells were mounted on slides using Dako anti-fading
mounting media. Optical sections were analyzed by confocal microscopy
or phase contrastmicroscopy on an invertedmicroscope (DM IRE2, Leica)
using a 63×/1.4 NA HC Plan 10×/25 objective lens (Leica). The contrast
was adjusted for all images with the same settings.2.6. Cell fractionation
The cells were harvested using hypotonic buffer and collected by
scraping. Lysates were incubated on ice for 10 min and then homog-
enized 5 times using a 19 G syringe. A sample was collected at this
point to represent the total lysate. Lysates were centrifuged at 800 g
at 4 °C for 15 min and the supernatant was collected and centrifuged
again at maximum speed for 15 min. The supernatant collected was
used as the cytoplasmic fraction. The pellet, corresponding to the
membrane cortex, was washed twice in hypotonic buffer followed by
centrifugation for 15 min at 2500 g at 4 °C. The washed pellet was
resuspended in RIPA buffer, and corresponds to the membrane cortical
fraction (referred to as the membrane cortex fraction in text).2.7. Co-immunoprecipitation and western blotting
Immunoprecipitation was performed on whole cell lysates resus-
pended in cold TNE buffer using the appropriate antibody at 4 °C O/N.
Immunoprecipitates were resolved on 10% or 8% SDS-PAGE. Proteins
were transferred to nitrocellulose (Millipore, Bedford, MA), immuno-
probed, and detected by enhanced chemiluminescence (Pierce
Chemical, Rockford, IL). Western blotting was performed with the
same antibodies used for the immunoprecipitation to control for
loading. Phosphatase treatment was performed as previously de-
scribed [5]. Lysate was treated with lambda phosphatase for
30 min and the reaction was stopped using a phosphatase inhibitor
(phosphoSTOP, Roche) and 50 mMNaF. The wild type Flag-Scrib-PDZ3
sequence and the K/A mutant were cloned in pcDNA3.1 (GeneArt, Life
Technologies, Mulgrave, VIC, Australia). The Scrib-PDZ3 sequence
was derived from the Scrib transcript variant 1 (NM_182706.4),
amino acids 1003–1092, and the K/A mutant harbored a lysine to al-
anine substitution at position 1040. The Flag-Scrib-PDZ3 protein was
immunoprecipitated using anti-Flag M2 Afﬁnity Gel (Sigma,
#A2220).3. Results
3.1. MCC PDZ-binding motif is phosphorylated at position−1, Serine 828
As phosphorylation at −2 regulates the binding activity of many
PDZ binding motifs, we performed a LC–MS/MS experiment to deter-
mine whether the MCC PDZ-binding motif is also phosphorylated at
this site. No phosphorylation was detected at the −2 position but
the Serine 828, at position −1, was phosphorylated in HCT116
(Fig. 1A) and SW480 colon cancer cells (data not shown). Despite
the large number of post-translational modiﬁcations in the PDZ-
binding motif, to our knowledge, no functional studies have been
reported on phosphorylation of the PDZ-binding motif residue −1
[14]. It is possible that this modiﬁcation has not been previously de-
scribed due to its close proximity with the threonine/serine residue
at position −2, thus making its identiﬁcation and validation by MS
difﬁcult. In our case, the presence of y2 ion in our MS/MS spectra
(Fig. 1A, orange arrow) allows unambiguous assignment of MCC
phosphorylation at Serine 828.
Remarkably, the importance of MCC PDZ-binding motif, and its
phosphorylation at position −1, is highlighted by the strong evolu-
tionary conservation. Hence, the only amino acid substitution within
this PDZ-binding motif is found in Drosophila at position −1 where
serine “ETSL” is substituted to another phosphorylable amino-acid
threonine “ETTL” (Fig. 1B). MCC has recently been shown to bind to
the polarity protein Scrib through its PDZ-binding motif [1]. The
MCC/Scrib interaction is also conserved between mammals and
ﬂies, since Drosophila MCC efﬁciently co-immunoprecipitates with
Drosophila Scribble [1].
Fig. 1.MCC PDZ-binding domain is phosphorylated at the position−1, Ser828. A. LC–MS/MS experiment identiﬁes phosphorylation of endogenous MCC at Serine 828. Endogenous
MCC was immunoprecipitated from HCT116 cells using N-terminal mouse monoclonal antibody. MCC was excised from the SDS-PAGE gel, digested with trypsin and peptides
were analyzed by LC/MS/MS. Search was performed using Mascot software. MS/MS spectra for the phospho-peptide IALLEEENSRPHTNET(pS)L, with annotated b and y ions, is
shown. Phosphorylation at serine −1 is indicated by the presence of y2 ion (+80 Da for the mass of the phosphate group) at m/z=299.1 (orange arrows). B. MCC PDZ-binding
motif is strongly conserved among species. Sequence alignment shows a high degree of conservation of MCC-PDZ-binding motifs between species, including a conserved phosphor-
ylable amino-acid at position −1.
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PDZ domains
Despite the general view of the−1 amino acid of the PDZ-binding
motif being randomly assigned, Scrib PDZ-1 and PDZ-3 domains pref-
erentially bind to motifs that have aspartic acid at the −1 position
[15], as summarized in Fig. 2A. Aspartic acid is an amino acid com-
monly used for its phosphomimetic properties, suggesting that phos-
phorylation of MCC at Serine 828 might increase its binding afﬁnity to
Scrib. In addition, the consensus prediction shows that in addition to
the last four amino acids forming a class 1 PDZ binding motif, amino
acids at positions −4 and −5 also inﬂuence the binding afﬁnity
(Fig. 2A). This analysis reveals a strong preference for aromatic
amino-acids (W, F, Y) at positions−4 and−5 giving a rational expla-
nation for the reported higher afﬁnity of β-PIX (WDETNL) for Scrib
(PDZ-1 and 3) compared to MCC (TNETSL) [1].
We ﬁrst conﬁrmed the interaction between MCC and Scrib by co-
immunoprecipitation (co-IP). HCT15 cells were transfected with
either a wild type (WT) or a MCC construct deleted of its PDZ-
binding motif (Δ). MCC was only detected in Scrib immunoprecipi-
tates from cells expressing the WT construct, conﬁrming that thisinteraction requires the PDZ-binding motif of MCC (last 4 C-
terminal amino-acids). We also conﬁrmed the interaction of MCC
with β-catenin [2], which is independent of the PDZ-binding motif
(Fig. 2B). As previously shown, MCC is a phosphoprotein that runs
as two closely migrating bands on low percentage polyacrylamide
gel representing MCC hyper- and hypo-phosphorylated forms [5].
We next ran the Scrib and β-catenin immunoprecipitates on a low
percentage polyacrylamide gel and blotted for MCC. This showed
that only the hyperphosphorylated form of MCC was found in com-
plex with Scrib (upper band, upper red arrow) (Fig. 2C). We next
treated the pre-IP lysate with lambda phosphatase and tested the
ability of Scrib to immunoprecipitate MCC. Our data show that
pre-treatment with lambda phosphatase strongly reduces the
amount of MCC bound to Scrib compared to control (Fig. 2D). We
next assessed the effect of MCC Ser828 phosphomutants on MCC/
Scrib interaction by co-IP. MCC Ser828 was mutated by site directed
mutagenesis to non-phosphorylable alanine (SA) or phosphomi-
metic aspartic acid (SD). As expected, mutation of Ser828 to alanine
resulted in partial loss of interaction with Scrib, compared to wild
type MCC, whereas substitution to aspartic acid had no detectable
effect (Fig. 2E).
Fig. 2. Phosphorylation of the PDZ-binding motif regulates its interaction with Scrib PDZ domains. A. A randomly generated peptide binding assay [15] shows that a high proportion
of PDZ-binding motifs interacting with Scrib PDZ domains 1 and 3, harbor an aspartic acid at position−1 (30% PDZ1 and 45% PDZ3). In addition to the last four amino acids forming
the PDZ class 1 consensus, amino acids at positions −4 and −5 also inﬂuence the binding afﬁnity. This consensus reveals a strong preference for aromatic amino acids (W, F, Y)
at positions−4 and−5 giving a rational explanation for the reported higher afﬁnity of β-PIX (WDETNL) for Scrib (PDZ1 and 3) compared to MCC (TNETSL) [1]. B. MCC–Scrib in-
teraction is dependent on the PDZ-binding motif of MCC. HCT15 cells transfected with MCC-WT (WT) or MCC-ΔETSL (Δ) was lysed and subjected to immunoprecipitation using
Scrib or β-catenin antibody. 10% of the whole lysate used for the co-IP was blotted for MCC to insure that equal amount of MCC-WT or MCC-ΔETSL was expressed. Scrib immuno-
precipitates were blotted for Scrib to ensure that equal amounts of Scrib were immunoprecipitated in the samples, and blotted for MCC. C. The same IPs were run on an 8% poly-
acrylamide gel and blotted for β-catenin, Scrib and MCC. This assay shows that a hyper-phosphorylated form of MCC binds to Scrib (top red arrow) whereas β-catenin
coimmunoprecipitates both hyper- and hypo-phosphorylated forms of MCC (lower and upper bands respectively, indicated by two red arrows). D. Lambda phosphatase treatment
reduces the interaction between Scrib and MCC. MCC-WT was transfected into HCT15 cells. Prior to immunoprecipitation the lysates were treated with lambda phosphatase or
mock-treated. 10% of the total lysates were blotted for MCC and pAKT to conﬁrm that dephosphorylation occurs and that equal amounts of MCC-WT were expressed. Immunopre-
cipitates were blotted for Scrib, to conﬁrm that an equal amount of Scrib was immunoprecipitated from each sample, as well as for MCC. E. Mutation of Ser828 to non-
phosphorylable alanine resulted in partial loss of interaction with Scrib whereas substitution to pseudo-phosphorylated aspartic acid appeared to have no effect. Vector-only
(Ø), MCC-WT (WT), MCC-S828A (SA) or MCC-S828D (SD) was transfected into HCT15 cells and immunoprecipitation was performed using Scrib antibody. 10% of the total lysates
used for co-IP were blotted for MCC to conﬁrm that equal amounts of MCC-WT and phosphomutants were expressed. Immunoprecipitates were run on a 10% polyacrylamide gel
and blotted for Scrib, to conﬁrm that an equal amount of Scrib was immunoprecipitated from each sample, as well as for MCC.
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The effect of phosphorylation at position −2 of the PDZ-binding
motif is well described and is predicted to prevent an interaction be-
tween the unphosphorylated serine/threonine at position −2 and a
histidine residue in the PDZ domain (Fig. 3A, blue arrow), subse-
quently weakening the PDZ interaction [14]. The way that residues
at position −1 interact with the PDZ domain is still open to debate
but an interaction with the ﬁfth residue of the third beta-sheet of
the PDZ domain (β3C5) is likely to be involved [16].
In agreement with this model, both Scrib PDZ-1 and PDZ-3, which
show poor overall identity (43%), harbor a basic residue at position
β3C5 (Fig. 3A, red arrow). In addition, alpha-carbon backbone repre-
sentation of Scrib-PDZ-1 shows the β3C5 arginine residue pointing
towards the PDZ-binding motif, represented as a thick red arrow
(Fig. 3B, left panel). The right panel shows Scrib PDZ1 hydrophobicity
representation with the hydrophobic PDZ groove in red (Fig. 3B, right
panel). Finally, multiple sequence alignment of Scrib PDZ-1 showsconservation of a positively charged residue at position β3C5 be-
tween species (Fig. 3C). Therefore, we tested the requirement of a
basic residue at position β3C5 of Scrib-PDZ3 by substituting it with
a non-charged alanine. WT and mutant versions of Scrib-PDZ3 were
co-expressed with MCC and tested for their ability to interact with
MCC by co-IP. Our data clearly show that lysine β3C5 to alanine sub-
stitution strongly reduces the ability of Scrib-PDZ3 to bind to MCC
(Fig. 3D).
3.4. MCC localizes at the leading edge of polarized cells
In order to address the functional role of MCC phosphorylation at
the PDZ-binding motif position −1, we ﬁrst examined endogenous
MCC intra-cellular localization by confocal microscopy. We detected
endogenous MCC at the leading edge of polarized MCF10A cells
where it co-localized with actin. MCC localization was conﬁned to
the outer margins of the lamellipodia structure as shown by phase
contrast cell imaging (Fig. 4A, white arrow), and relative clearing
within the inner margins (Fig. 4A, white brackets). This staining was
Fig. 3. Mutation of a basic residue at position of β3C5 of Scrib-PDZ3 reduces the binding with MCC. A. Sequence alignment of Scrib-PDZ1 and 3 shows a basic residue at position
β3C5 (red arrow) and a histidine residue in the alpha helix2 (blue arrow) for both Scrib PDZ 1 and 3. Protein Scribble homolog isoform a [Homo sapiens] ref: NP_874365.2. B.
The conserved β3C5_Arg residue points toward the hydrophobic PDZ binding pocket. PDZ binding motif is represented by a red arrow (N- to C-terminal). Representation of
Scrib-s (PDB 2W4F) alpha carbon backbone (left) and hydrophobicity CPK (right). The ﬁgure was made using Jmol. C. Multiple sequence alignment of Scrib PDZ1 between species
shows conservation of a positively charged residue at position β3C5. Multiple alignments were performed using the software ClustalW2.1. The conserved positively charged residue
β3C5 (red arrow) and the histidine residue in alpha2 that hydrogen bonds with Ser/Thr at position (−2) of the peptide, are shown in red. Secondary structure elements are indi-
cated at the bottom of the alignment as yellow arrow (beta strand) and red sinusoidal (alpha helix). D. The lysine to alanine mutation of residue β3C5 strongly reduces the binding
of Scrib-PDZ3 with MCC. HCT15 cells were transfected with Flag-Scrib-PDZ3-WT (WT)/vector-alone (Ø), Flag-Scrib-PDZ3-WT (WT) /MCC-WT, or Flag-Scrib-PDZ3 mutated at po-
sition β3C5 (K/A) /MCC-WT. Flag-Scrib-PDZ3 WT or the K/A mutant were immunoprecipitated using Flag M2 Afﬁnity Gel and the immunoprecipitates were blotted for MCC and
Flag.
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cortactin [17].
Similar to endogenous MCC, exogenous wild type MCC co-localized
with actin at lamellipodia (white arrow) and along spike-like ﬁlopodia(blue arrow) in polarized Caco2 cells. Endogenous MCC expression in
Caco2 cells is almost absent and is not detectable by immunoﬂuores-
cence (Fig. 4B). Heat map intensity gradient also clearly indicated exog-
enous MCC accumulating along the ﬁlopodia extensions (Fig. 4B,
Fig. 4.MCC localizes at the leading edge of polarized cells. MCC sub-cellular localization was assessed by immunoﬂuorescence and confocal acquisition. A. MCF10A cells were grown
O/N on coverslips, permeabilized, ﬁxed and stained using MCC antibody. FITC-conjugated phalloidin was used to stain actin. White arrow indicates MCC localizing at lamellipodia.
White bracket indicates the inner margins. Higher magniﬁcation: MCC/phalloidin co-localization in lamellipodia. B. Exogenous MCC localizes at the leading edge of polarized Caco2
cells. MCC was over-expressed for 36 h in Caco2 cells and was stained using MCC antibody. FITC-conjugated phalloidin was used to stain actin. White arrow indicates lamellipodia
and blue arrow indicates ﬁlopodia. C. MCC is present in the membrane cortex fraction of MCF10A cells. Total lysate (TL), membrane (Mb) and cytoplasmic (Cyto) fractions from
MCF10A cells were run on a 10% polyacrylamide gel and blotted for MCC and Scrib. E-cadherin (membrane marker) and AKT (cytoplasmic marker) were used to assess the purity
of the fractionation.
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presence of endogenous MCC in the membrane cortical fraction
(Fig. 4C).
3.5. Expression of MCC bearing the substitution of Serine 828 to aspartic
acid but not to alanine reduces the formation of lamellipodia
We next assessed the impact of MCC Ser828 phosphomutants on
lamellipodia formation. MCC-WT or MCC phosphomutants (S828A
or S828D) were expressed in Caco2 cells for 36 h and the cells were
assessed for their ability to form lamellipodia. Cells expressing the
phospho-deﬁcient mutant (S828A) were able to maintain lamellipo-
dia formation at levels indistinguishable from cells expressing wild
type MCC, whereas cells expressing the phospho-mimetic mutant
(S828D) showed reduced lamellipodia formation (Fig. 5A). Represen-
tative confocal images of Caco2 cells expressing MCC-WT or the MCC-
S828 phosphomutants are shown in Fig. 5B.
We next assessed the ability of MCC phosphomutants to localize at
lamellipodia by assessing MCC staining by confocal microscopy. We
found that localization of MCC at the lamellipodia is strongly affected
by mutation of Ser828. Hence, although MCC-S828D expressing cells
had fewer lamellipodia, the intensity of MCC staining at the mem-
brane was stronger (Fig. 5C). Hence, more than 50% of the cells ex-
pressing MCC-S828D show high ﬂuorescence MCC intensity at thelamellipodia, compared to less than 30% for MCC-WT and MCC-
S828A. These results suggest that excess MCC-S828D protein at the
membrane cortex could be detrimental to lamellipodia formation.
Representative confocal images of MCC staining intensity and scoring
are shown (Fig. 5D).
Finally, consistent with a loss of cell migration following MCC
knockdown [1], expression of MCC deleted of its PDZ-binding domain
resulted in a severe reduction of lamellipodia formation and mem-
brane localization (Fig. 5A–D).
3.6. MCC interacts with Myosin-IIB in a PDZ-independent manner and
expression of MCC-S828D, but not MCC-S828A, resulted in Myosin-IIB
accumulation at the membrane cortex
Scrib/β-PIX has been shown to participate in lamellipodia forma-
tion through the activation of PAK1 at the leading edge of migratory
cells [10]. However, loss of migration caused by MCC knockdown
was not associated with altered PAK1 activation in a previous study
[1]. We have further shown that expression of the MCC-S828D mu-
tant reduced lamellipodia formation while still binding to Scrib, sug-
gesting that additional proteins, other than Scrib, are likely to be
affected by re-expression of the MCC-S828D mutant.
We focused our attention on Myosin-IIB, a non-muscle motor pro-
tein implicated in lamellipodia formation [18] and identiﬁed as a
Fig. 5. Expression of MCC bearing the substitution Serine 828 to aspartic acid but not to alanine reduces the formation of lamellipodia. A. Percentage of Caco2 cells expressing MCC-
WT, MCC-ΔETSL or phosphomutants forming lamellipodia. Graph values represent the mean percentage and standard deviation of MCC expressing cells which display lamellipodia
formation. B. Representative ﬁeld of Caco2 cells expressing MCC-WT (WT), MCC-ΔETSL, MCC-S828A (SA) or MCC-S828D (SD) using confocal microscopy. Caco2 cells were trans-
fected with MCC-WT, MCC-ΔETSL, MCC-S828A or MCC-S828D for 36 h before being stained for MCC. C. Scoring of MCC intensity at the lamellipodia. Caco2 lamellipodia positive cells
expressing MCC wild type or mutant were scored for MCC intensity at the lamellipodia. Graph values represent the mean score of MCC intensity at lamellipodia and the deviation
from the mean. D. Representative confocal images of the different MCC intensity staining of MCC at the lamellipodia.
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[19] and recently conﬁrmed by us [4]. Myosin-IIB is a critical genera-
tor of contractile force during cell migration by re-organizing the
cytoskeleton including lamellipodia formation [18]. We conﬁrmed
that the binding of MCC with Myosin-IIB is independent of the PDZ-
binding motif of MCC (Fig. 6A). To conﬁrm the relevance of MCC/Myo-
sin-IIB interaction in lamellipodia formation, the subcellular localization
of both endogenous proteins was determined. MCC and Myosin-IIB
clearly co-localized at the leading edge of migrating MCF10A cells
(Fig. 6B).
Among the many kinases regulating Myosin-IIB activity is PAK1,
which reduces myosin light chain (MLC) phosphorylation through
MLCK inhibition, and increases Myosin-IIB heavy chain phosphoryla-
tion by activating aPKC-zeta. These modiﬁcations are part of complex
signaling pathways which vary in different cellular conditions, and
result in a dynamic assembly/disassembly of myosin ﬁlaments at
the membrane cortex which is required for lamellipodia formation
[20]. However, the detailed mechanism of the full process is poorly
understood and is likely to involve modiﬁcation of several amino
acids in the Myosin-IIB heavy chain [21,22].
We hypothesized that expression of MCC-S828Dmutant could im-
pair lamellipodia formation by interfering with the normal subcellu-
lar localization of Myosin-IIB and its regulation by PAK1. To test this
hypothesis, we exogenously expressed MCC-WT, MCC-S828A or
MCC-S828D in Caco2 cells for 36 h. Our cell fractionation data clearlyshowed that the amount of Myosin-IIB was increased in the mem-
brane cortex fraction of MCC-S828D expressing cells compared to
MCC-WT, MCC-S828A or mock transfected cells (Fig. 6C). Similarly,
accumulation of Myosin-IIB at the membrane cortex was evident in
MCC-S828D but not in S828A expressing cells by immunoﬂuores-
cence microscopy (Fig. 6D and E). This resembles the phenotype ob-
served after transfection of a dominant negative PAK1 mutant
(devoid of kinase activity) in a prostate cancer cell line [20]. This
PAK1 mutant was associated with defective Myosin-IIB ﬁlament dis-
assembly at the membrane cortex and a lamellipodia defect. This in-
crease in Myosin-IIB at the membrane cortex is consistent with the
observed “contracted” morphology of MCC-S828D expressing cells
(Fig. 5B) and reduced lamellipodia formation (Fig. 5A).
These data suggest that the phosphomimetic mutant MCC-S828D,
“locks in” a phenotype, where Myosin-IIB is trapped in the membrane
cortex and lamellipodia formation is reduced.
4. Discussion
Following our previous work on the role of MCC phosphorylation
in the DNA damage response [5] we now report a new phosphoryla-
tion of MCC within its PDZ-binding domain at position −1 and its
role in lamellipodia formation. This work presents the ﬁrst functional
characterization of phosphorylation of the PDZ-binding motif at
position −1.
Fig. 6. MCC interacts with Myosin-IIB in a PDZ-independent manner and expression of MCC-S828D but not MCC-S828A increases the amount of Myosin-IIB at the membrane. A.
MCC interacts with Myosin-IIB independently of its PDZ-binding motif. HCT15 cells were transfected with vector only (Ø), MCC-WT (WT) or MCC-ΔETSL (Δ) for 36 h. Immunopre-
cipitation was performed using Myosin-IIB antibody or IgG control and run on a 10% polyacrylamide gel. 10% of the total lysate used for co-IP was run to show that a similar amount
of MCC-WT and MCC-ΔETSL was expressed. Gel was blotted for Myosin-IIB, MCC and Gapdh. B. Endogenous MCC co-localizes with Myosin-IIB at the lamellipodia. Endogenous MCC
(red) co-localized with endogenous Myosin-IIB (green) in polarized MCF10A cells. Higher magniﬁcation: MCC/Myosin-IIB co-localization in the lamellipodia. C. Caco2 cells were
transfected with vector only (Ø), MCC-WT (WT), MCC-S828A (SA) or MCC-S828D (SD) for 36 h. 5 μg of membrane (M) or cytoplasmic (C) fraction was loaded and gel was blotted
for Myosin-IIB, MCC and total PAK. E-cadherin and Gapdh were used as membrane and cytoplasmic markers respectively. D. Caco2 cells were transfected with MCC-WT, MCC-
S828A or MCC-S828D for 36 h before being stained for MCC and Myosin-IIB. Graph values represent the mean score of Myosin-IIB intensity at lamellipodia in MCC expressing
cells and the deviation from the mean. E. Representative confocal images of the different Myosin-IIB intensity staining at the lamellipodia of MCC expressing Caco2 cells.
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is characterized by the sequence X-(S/T)-X-(V/L/I), where X at posi-
tion −1 is any amino acid. The PDZ-binding motif is one of the
most common protein–protein interaction motifs and phosphoryla-
tion at position −2 of the class I motif is widely reported as a way
to modulate this type of interaction [14]. Despite the large number
of proteins harboring PDZ-binding motifs (>250) in the human ge-
nome, phosphorylation has only been described at positions p(−2)
to p(−10) but not at p(0) or p(−1) [14]. The residue at position
−1 of the PDZ binding motif was originally described as unimportant
for PDZ interaction [23]; however, a number of studies are now slow-
ly changing this view [24,25].In an attempt to address the importance of this newly character-
ized PDZ-binding motif modiﬁcation, we undertook an in silico
search, which revealed that 146 proteins contain a class 1 PDZ-
binding motif with a phosphorylable amino acid at position −1 [S/T]
[S/T][L/V/I]-COOH. Importantly, phosphorylation has been found for
31 of them in large-scale phosphomapping studies (Fig. 7 and Sup-
plementary Table 1), highlighting the potential signiﬁcance of this
post-translational modiﬁcation in a wide range of cellular processes.
The effect of phosphorylation at position −2 of the PDZ-binding
motif is well described and is predicted to prevent an interaction be-
tween the unphosphorylated serine/threonine at position −2 and a
histidine residue in the PDZ domain, subsequently weakening the
Fig. 7. Sub-cellular and functional classiﬁcation of 146 proteins harboring a class 1 PDZ binding motif with a phosphorylable amino-acid at position−1. As expected, the majority of
these proteins are found at the membrane. Within the membrane fraction (left pie chart), 64% are transmembrane proteins (42% receptor and 22% channel) supporting a role for
this phosphorylation in membrane transport and membrane signal transduction. On the other hand, 22% of the proteins in the non-membrane fraction (right pie chart) are nuclear
proteins having a role in transcription/translation, highlighting the role of this post-translational modiﬁcation in a multitude of biological functions.
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with the PDZ domain is still open to debate but an interaction with
the ﬁfth residue of the third beta-sheet of the PDZ domain (β3C5) is
likely to be involved [14,16]. Several studies also suggest a correlation
between the presence of a charged β3C5 residue within the PDZ
domain and an oppositely charged residue at position −1 of the
PDZ-binding motif, supporting an electrostatic type of interaction or
a salt bridge [26,27]. In agreement with this model, a randomly
generated peptide binding assay identiﬁed aspartic acid (acidic resi-
due) as the preferential −1 residue interacting with Scrib PDZ-1
and −3 (Fig. 2A), which harbor a basic residue at position β3C5 in
close proximity to the interacting PDZ-binding motif in the crystal
structure (Fig. 3A and B). Furthermore, as shown here, substitution
of the lysine residue at Scrib PDZ3 β3C5 for alanine strongly reduced
the MCC/PDZ3 interaction, providing further evidence for this binding
mechanism.
Therefore, contrary to the effect of phosphorylation at residue−2, our
data suggest that phosphorylation of MCC at serine−1 could increase its
binding afﬁnity with Scrib. As predicted, our co-immunoprecipitation
assay shows a reduction in binding afﬁnity between Scrib and MCC-
S828A (non-phosphorylable amino acid) compared to MCC-WT and a
reduction in MCC binding to Scrib following phosphatase treatment.
However, despite the in vitro prediction, no detectable difference was
observed between MCC-S828D (pseudo-phosphorylated) and MCC-
WT. It is possible that this is because themajority of MCC-WT is already
phosphorylated at Ser828 in these cells.
Finally, the importance of MCC/Scrib interaction, the MCC PDZ-
binding motif, and its phosphorylation at position−1, is highlighted
by the strong evolutionary conservation. Hence, in addition to a reported
interaction betweenMCC and Scrib (scribble) inDrosophila [1], conserva-
tion analyses also predict that phosphorylation at position−1 is likely to
be conserved. The only amino acid substitution within the PDZ-binding
motif is found in Drosophila at position −1 where the serine “ETSL” is
substituted to another phosphorylable amino acid threonine “ETTL”
(Fig. 1B).
Based on the data reported here, we propose that phosphorylation
of theMCCPDZ-bindingmotif in the−1 position regulates lamellipodiaformation. We also propose that this function could be mediated
through the formation of a transient complex that contains MCC, Scrib
andMyosin-IIB.We found thatMCC interacts withMyosin-IIB indepen-
dently of its PDZ-binding domain and that MCC and Myosin-IIB co-
localize at the migratory edge of the cells (Figs. 4A, 6A and B). We
next found that expression ofMCC-S828D, but notMCC-S828A, resulted
in Myosin-IIB accumulation at the membrane cortex (Fig. 6C) and loss
of lamellipodia. These results are similar to the phenotype observed
following expression of a PAK1 dominant negative mutant, which
lacks its kinase domain [20]. Hence, expression of PAK1DN, a binding
partner of the Scrib complex, resulted in excess Myosin-IIB accumu-
lation at the membrane cortex and aberrant lamellipodia formation.
This PAK1 mutant was associated with defective Myosin-IIB ﬁla-
ment disassembly at the membrane cortex.
Further work is required to determine how the MCC-S828D/Scrib/
Myosin-IIB interactions might cause reduced lamellipodia formation
but this could involve dysregulation of myosin ﬁlament assembly/
disassembly. Based on our data, we propose a model in which efﬁcient
lamellipodia formation requires cyclic association/dissociation of a
MCC/Myosin-IIB complex with Scrib. While the majority of MCC in the
cell is phosphorylated on S828, a small pool at the cell cortex undergoes
regulated phosphorylation/dephosphorylation at this residue and this
regulates the binding afﬁnity of MCC towards Scrib. Dephosphorylation
represents a critical element of this regulation mechanism and in its
absence, as modeled by MCC S828D, the protein complex cannot disso-
ciate, resulting in prolonged localization of MCC/Myosin-IIB at the cell
cortex and impaired lamellipodia formation.
In conclusion, this study presents the ﬁrst functional characteri-
zation of phosphorylation at position −1 of the PDZ-binding motif
unveiling another level of regulation of PDZ–ligand interaction.
Contrary to phosphorylation at position −2, we propose that
phosphorylation at position −1 might increase the binding afﬁnity
possibly through the formation of an additional interaction with
the residue β3C5 of the PDZ domain. Future work will now try to ad-
dress the detailed mechanism by which phosphorylation of Ser828
affects MCC/Scrib binding, Myosin-IIB function and lamellipodia
formation.
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